BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22098725)

  • 1. Are SCN1A gene mutations responsible for genetic susceptibility to subacute sclerosing panencephalitis?
    Garg RK
    Med Hypotheses; 2012 Feb; 78(2):247-9. PubMed ID: 22098725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute sclerosing panencephalitis.
    Garg RK; Mahadevan A; Malhotra HS; Rizvi I; Kumar N; Uniyal R
    Rev Med Virol; 2019 Sep; 29(5):e2058. PubMed ID: 31237061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
    Bayat A; Hjalgrim H; Møller RS
    Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature.
    Singer C; Lang AE; Suchowersky O
    Mov Disord; 1997 May; 12(3):342-53. PubMed ID: 9159729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 gene polymorphism in children with subacute sclerosing panencephalitis.
    Piskin IE; Calık M; Abuhandan M; Kolsal E; Celik SK; Iscan A
    Neuropediatrics; 2013 Aug; 44(4):187-90. PubMed ID: 23504559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments.
    Schmitz KS; Handrejk K; Liepina L; Bauer L; Haas GD; van Puijfelik F; Veldhuis Kroeze EJB; Riekstina M; Strautmanis J; Cao H; Verdijk RM; GeurtsvanKessel CH; van Boheemen S; van Riel D; Lee B; Porotto M; de Swart RL; de Vries RD
    J Virol; 2024 Mar; 98(3):e0187423. PubMed ID: 38329336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial subacute sclerosing panencephalitis in two siblings.
    Tuxhorn IE
    Pediatr Neurol; 2004 Oct; 31(4):291-4. PubMed ID: 15464644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dravet syndrome: new potential genetic modifiers, imaging abnormalities, and ictal findings.
    Gaily E; Anttonen AK; Valanne L; Liukkonen E; Träskelin AL; Polvi A; Lommi M; Muona M; Eriksson K; Lehesjoki AE
    Epilepsia; 2013 Sep; 54(9):1577-85. PubMed ID: 23808377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the likelihood of SCN1A microdeletions or duplications in Dravet syndrome with missense mutation.
    Shi X; Wang J; Kurahashi H; Ishii A; Higurashi N; Kaneko S; Hirose S
    Brain Dev; 2012 Sep; 34(8):617-9. PubMed ID: 22206733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.
    Angius F; Smuts H; Rybkina K; Stelitano D; Eley B; Wilmshurst J; Ferren M; Lalande A; Mathieu C; Moscona A; Horvat B; Hashiguchi T; Porotto M; Hardie D
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile infection-related epilepsy syndrome is not caused by SCN1A mutations.
    Carranza Rojo D; Harvey AS; Iona X; Dibbens LM; Damiano JA; Arsov T; Gill D; Freeman JL; Leventer RJ; Vincent A; Berkovic SF; McMahon JM; Scheffer IE
    Epilepsy Res; 2012 Jun; 100(1-2):194-8. PubMed ID: 22386634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
    Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
    Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE).
    Dyken PR
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):217-25. PubMed ID: 11553938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute sclerosing panencephalitis (SSPE).
    Lapointe N; Geoffroy G; McLaughlin B; Mongeau JG
    Birth Defects Orig Artic Ser; 1975; 11(1):239-43. PubMed ID: 1096980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dravet syndrome, what is new?
    Al-Baradie RS
    Neurosciences (Riyadh); 2013 Jan; 18(1):11-7. PubMed ID: 23291792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two mild cases of Dravet syndrome with truncating mutation of SCN1A.
    Takaori T; Kumakura A; Ishii A; Hirose S; Hata D
    Brain Dev; 2017 Jan; 39(1):72-74. PubMed ID: 27544716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of SCN1A genetic mutation in patients with hemiconvulsion-hemiplegia-epilepsy syndrome.
    Kim DW; Lim BC; Kim KJ; Chae JH; Lee R; Lee SK
    Epilepsy Res; 2013 Oct; 106(3):440-5. PubMed ID: 23916143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute sclerosing panencephalitis.
    Garg RK
    J Neurol; 2008 Dec; 255(12):1861-71. PubMed ID: 18846316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroencephalographic features of patients with SCN1A-positive Dravet syndrome.
    Lee HF; Chi CS; Tsai CR; Chen CH; Wang CC
    Brain Dev; 2015 Jun; 37(6):599-611. PubMed ID: 25459968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.